|
八珍汤治疗单节段腰椎退行性疾病开放TLIF手术围手术期隐性失血疗效观察
|
Abstract:
目的:观察八珍汤治疗单节段腰椎退行性疾病开放TLIF (transforaminal lumbar interbody fusion, TLIF)手术围手术期隐性失血疗效。方法:接受开放TLIF手术治疗的单节段腰椎退行性病变患者七十例被纳入研究,并通过随机的数字表法区分为使用八珍汤的组(35例)、不服用中药的对照组(35例)。临床评价包括血红蛋白、总失血量、显性失血量、隐性失血量、腰痛VAS (visual analog score, VAS)评分、下肢痛VAS评分、腰椎JOA (Japanese Orthopedic Association, JOA)评分,结果:治疗组患者的总失血量、显性失血量、隐性失血量、术前术后血红蛋白丢失均小于对照组(P < 0.05),治疗组患者术后腰痛VAS评分、术后下肢痛VAS评分、术后腰椎JOA评分均优于对照组(P < 0.05)。结论:单节段腰椎退行性疾病开放TLIF手术后予患者服用八珍汤,能在一定程度上减少患者总失血量、显性失血量、隐性失血量,加速术后康复,提升生存质量。
Objective: To observe the efficacy of Bazhen Decoction in the treatment of recessive blood loss during perioperative period after open TLIF (transforaminal lumbar interbody fusion, TLIF) operation for single-level lumbar degenerative diseases. Methods: Seventy patients with single-level lumbar degenerative disease who underwent open TLIF surgery were enrolled and randomly divided into bazhen Decoction group (35 cases) and control group (35 cases) by number table. Clinical evaluation included hemoglobin, total blood loss, dominant blood loss, recessive blood loss, lumbar VAS (visual analog score, VAS) score, lower limb VAS score, and lumbar JOA (Japanese Orthopedic Association, JOA) score. Results: Total blood loss, dominant blood loss, recessive blood loss, and preoperative and postoperative hemoglobin loss in the treatment group were all lower than those in the control group (P < 0.05). Postoperative lumbar VAS score, postoperative lower limb VAS score and postoperative lumbar JOA score in the treatment group were better than those in the control group (P < 0.05). Conclusion: Bazhen Decoction can reduce total blood loss, dominant blood loss and recessive blood loss in patients with single-level lumbar degenerative disease after TLIF operation to a certain extent, and accelerate postoperative recovery, improve the quality of life.
[1] | 刘京宇, 张巧云, 周谋望, 邢剑, 侯树勋, 吴新宝, 王宁华, 谢欲晓, 海涌, 顾新, 马华松, 马远征. 腰椎退行性疾病术后功能恢复的影响因素研究[J]. 中国康复医学杂志, 2019, 34(8): 907-912. |
[2] | 刘祥法, 刘鹏. 经椎间孔腰椎椎体间融合术联合补肾活血方治疗腰椎间盘突出症的疗效[J]. 安徽医学, 2020, 41(3): 327-329. |
[3] | 张曦, 王斌. 补肾活血汤治疗老年性股骨粗隆间骨折围手术期隐性失血疗效观察[J]. 中医药临床杂志, 2022, 34(1): 164-167. https://doi.org/10.16448/j.cjtcm.2022.0136 |
[4] | 万云芳, 许黎柳, 杨雯, 蒋毅, 娄桢祺. MIS-TLIF与开放TLIF治疗单节段腰椎退行性疾病围手术期失血量的对比研究[J]. 全科医学临床与教育, 2022, 20(1): 75-77. https://doi.org/10.13558/j.cnki.issn1672-3686.2022.001.022 |
[5] | 孙浩林, 李淳德, 刘宪义, 邑晓东, 刘洪, 卢海霖, 李宏, 于峥嵘, 赵硕. 腰椎融合术后症状性邻近节段退变的临床特点和再手术治疗[J]. 北京大学学报(医学版), 2012, 44(6): 855-859. |
[6] | 徐薇, 许德荣, 任志楠, 陈鑫, 张圣洁. 腰椎多节段内固定术中失血量准确评估的研究[J]. 中华骨与关节外科杂志, 2018, 11(7): 535-537. |
[7] | 张睿, 林国雄, 高敏, 张林胜, 邢飞. 经椎间孔腰椎椎体间融合术围手术期隐性失血的相关因素分析[J]. 现代医药卫生, 2020, 36(12): 1802-1804. |
[8] | 王志明, 刘永恒, 吴俊哲. 八珍汤在老年股骨粗隆间骨折围术期血液管理中的临床应用[J]. 内蒙古中医药, 2021, 40(4): 10-12. https://doi.org/10.16040/j.cnki.cn15-1101.2021.04.005 |
[9] | 郑赛赛, 刘卉. 八珍汤加减治疗青春期减重致闭经验案1则[J]. 世界最新医学信息文摘, 2019, 19(6): 267. https://doi.org/10.19613/j.cnki.1671-3141.2019.06.143 |
[10] | 李飞舟, 黄锡婷, 张海, 刘世琴. 以ODI为指导的中西医结合康复疗法在老年腰椎间盘突出症中的作用[J]. 中国老年学杂志, 2020, 40(23): 5004-5007. |
[11] | 陈玉春, 王碧英, 高依卿. 八珍汤对红细胞生成素影响的动物实验研究[J]. 上海中医药杂志, 2000, 34(4): 45-46. https://doi.org/10.16305/j.1007-1334.2000.04.022 |
[12] | 高依卿, 陈玉春, 王碧英. 八珍汤对粒系、单核系细胞养血补血作用机理的研究[J]. 中医研究, 2000, 13(2): 22-25. |
[13] | 潘洪平. 八珍汤的药理研究和临床应用[J]. 中成药, 2003, 25(11): 90-92. |